Blink Health commits $10M to give patients year's supply of common diabetes meds

NEW YORK —Blink Health has announced an effort to bring $10 million worth of free Type 2 diabetes medications to patients using the prescription drug savings platform.

Patients with diabetes who create an account on the Blink Health website or mobile app will be able to receive a year’s supply of metformin, glipizide and pioglitazone for free. The progam also will cover existing Blink Health users who take these medications, the company said.

“Overall, diabetes is a growing epidemic that affects 1-in-11 Americans, and Blink Health is committed to doing all it can to help patients manage this chronic illness,” Blink Health CEO and co-founder Geoffrey Chaiken said. “We have seen far too many people who are struggling to afford prescription medication, and we've launched this program to help address the problem one patient at a time.”

Blink Health said that any patient prescribed the diabetes drugs are eligible for the program, adding that the program would continue until the $10 million is exhausted. Patients can pick up the medications at more than 57,000 pharmacies nationwide, the company said.

Blink Health also is working with Eli Lilly to bring a 40% discount on Lilly insulins, which include Humalog, for Blink Health patients.